Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and "novel agent" therapy

Int J Hematol. 2015 Oct;102(4):391-3. doi: 10.1007/s12185-015-1863-4. Epub 2015 Sep 10.

¹ Immunohematology and Trasfusion Service, Civic Hospital, Nazario Sauro Street, 25, 30027, San Donà Di Piave, Venice, Italy. lorenza.torti@libero.it.
² Clinical Hematology, Department of Hematology, Transfusion Medicine and Biotechnology, "Spirito Santo" Civic Hospital, Pescara, Italy. lorenza.torti@libero.it.
³ Clinical Hematology, Department of Hematology, Transfusion Medicine and Biotechnology, "Spirito Santo" Civic Hospital, Pescara, Italy.
⁴ Section of Hematopathology, Department of Hematology and Oncological Sciences, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

No abstract available

Keywords: Immunodeficiency; Leishmaniasis; Multiple myeloma; Novel agents; Opportunistic infections.

Publication types